세계의 임상 워크플로우 솔루션 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 최종 사용별, 지역별, 부문 동향(2023-2030년)

Clinical Workflow Solutions Market Growth & Trends

The global clinical workflow solutions market size is estimated to reach USD 24.37 billion by 2030, growing at a CAGR of 12.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The need for clinical process automation is expanding, especially in developed countries like the U.S., and rising initiatives from public and commercial organizations are changing the healthcare sector. The need for scalable healthcare systems has been further spurred by the requirement to give clinicians remote access to data insights. For instance, according to a survey conducted by OmniLife Health in March 2023, over 30% of the U.S. hospitals, health systems, and transplant centers have already implemented Clinical Workflow Automation (CWA), which is expected to rise to 61% by 2024.

In addition, 48% of companies utilizing CWA want to deploy it in more clinical settings by 2023. Given that some respondents wrongly assume their current EHR vendor or simple software programs may deliver CWA functions, the expansion of CWA is anticipated to continue as there is still substantial scope for expanded adoption. The adoption rate is anticipated to increase as public knowledge and comprehension of CWA grow.

Healthcare providers have faced substantial hurdles during the COVID-19 epidemic, highlighting the need for remote access to data insights and effective clinical procedures. As a result, businesses are expanding their markets and engaging in more acquisitions to diversify and synchronize their product portfolios. For instance, in December 2021, Fortive announced to pay USD 1.4 billion to acquire Provation, a provider of clinical workflow solutions. This tactical move strengthens Fortive's position in crucial workflow solutions for hospitals and ambulatory surgical centers (ASCs) and aligns with the company's Advanced Healthcare Solutions (AHS) segment.

To maintain a strong competitive advantage, market participants are actively investing in creating and introducing innovative products. For instance, in February 2023, bioMerieux launched MAESTRIA, a cutting-edge middleware solution for the clinical microbiology laboratory. As a centralized software solution, MAESTRIA streamlines operations and improves operational efficiency by managing the workflow of everyday tasks. This strategic decision demonstrates the market's competitors' dedication to providing innovative, all-inclusive solutions to satisfy clinical laboratories' changing demands.

Furthermore, the market is also expanding due to the rising demand for AI-assisted technology, which is renowned for minimizing errors and assisting with clinical decision-making. This tendency will persist with the launch and adoption of additional AI-assisted technologies. For instance, in October 2022, ConcertAI's TeraRecon unveiled TeraRecon Neuro, an AI-assisted clinical workflow solution created to solve time issues in neurovascular crises for the whole care team.

Clinical Workflow Solutions Market Report Highlights

• Based on type, the data integration solutions category dominated the market with a share of 26.53% in 2022. Owing to the increasing amounts of data and the demand for integrated solutions to lower escalating costs, healthcare providers have chosen data integration technologies
• Based on end-use, the hospitals segment led the market with a revenue share of 44.9% in 2022. This is attributed to the extensive use of clinical workflow solutions in hospitals and the increased number of healthcare institutions requiring efficient data management and privacy protection
• The North America region dominated the market with a revenue share of 41.84% in 2022. The increasing R&D activities and hospital patient admission lead to a high volume of data generated and increasing government initiatives regarding the effective usage of interoperability provide the market with the largest revenue contribution
• Several companies are actively collaborating to promote innovation in workflow solutions. For instance, Innovaccer and Roche announced a collaboration to provide clinical decision support and workflow solutions in September 2021. Such collaborations are critical in driving the market acceptance and development of efficient workflow solutions

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing patient volume due to the rising prevalence of diseases
    • 3.2.1.2. Increasing government initiatives for the adoption of clinical workflow solutions
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data privacy and security concerns
    • 3.2.2.2. High cost of Clinical workflow management systems
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

• 4.1. Clinical Workflow Solutions Market: Type Movement Analysis
• 4.2. Data integration solution
  • 4.2.1. Data integration solution Market, 2018 - 2030 (USD Million)
  • 4.2.2. EMR integration solutions Market, 2018 - 2030 (USD Million)
  • 4.2.3. Medical Image Integration Solutions/imaging workflow solutions Market, 2018 - 2030 (USD Million)
• 4.3. Real time communication solution
  • 4.3.1. Real time communication solution Market, 2018 - 2030 (USD Million)
  • 4.3.2. Nurse Call Alert Systems Market, 2018 - 2030 (USD Million)
  • 4.3.3. Unified Communication Solutions Market, 2018 - 2030 (USD Million)
• 4.4. Workflow automation solution
  • 4.4.1. Workflow automation solution Market, 2018 - 2030 (USD Million)
  • 4.4.2. Patient Flow Management Solutions Market, 2018 - 2030 (USD Million)
  • 4.4.3. Nursing & Staff Scheduling Solutions Market, 2018 - 2030 (USD Million)
• 4.5. Care collaboration solution
  • 4.5.1. Care collaboration solution Market, 2018 - 2030 (USD Million)
  • 4.5.2. Medication Administration Solutions Market, 2018 - 2030 (USD Million)
  • 4.5.3. Perinatal Care Management Solutions Market, 2018 - 2030 (USD Million)
  • 4.5.4. Rounding Solutions Market, 2018 - 2030 (USD Million)
  • 4.5.5. Other Care Collaboration Solutions Market, 2018 - 2030 (USD Million)
• 4.6. Enterprise reporting and analytics solution
  • 4.6.1. Enterprise reporting and analytics solution market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

• 5.1. Clinical Workflow Solutions Market: End-Use Movement Analysis
• 5.2. Hospitals
  • 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.3. Long-term care facilities
  • 5.3.1. Long-term care facilities Market, 2018 - 2030 (USD Million)
• 5.4. Ambulatory care centers
  • 5.4.1. Ambulatory care centers Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Clinical Workflow Solutions Market Share By Region, 2022 & 2030
• 6.2. North America
  • 6.2.1. SWOT Analysis
  • 6.2.2. North America Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.2.3. U.S.
    • 6.2.3.1. Key Country Dynamics
    • 6.2.3.2. Target Disease Prevalence
    • 6.2.3.3. Competitive Scenario
    • 6.2.3.4. Regulatory Framework
    • 6.2.3.5. U.S. Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.2.4. Canada
    • 6.2.4.1. Key Country Dynamics
    • 6.2.4.2. Target Disease Prevalence
    • 6.2.4.3. Competitive Scenario
    • 6.2.4.4. Regulatory Framework
    • 6.2.4.5. Canada Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
• 6.3. Europe
  • 6.3.1. SWOT Analysis
  • 6.3.2. Europe Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.3. UK
    • 6.3.3.1. Key Country Dynamics
    • 6.3.3.2. Target Disease Prevalence
    • 6.3.3.3. Competitive Scenario
    • 6.3.3.4. Regulatory Framework
    • 6.3.3.5. UK Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.4. Germany
    • 6.3.4.1. Key Country Dynamics
    • 6.3.4.2. Target Disease Prevalence
    • 6.3.4.3. Competitive Scenario
    • 6.3.4.4. Regulatory Framework
    • 6.3.4.5. Germany Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.5. France
    • 6.3.5.1. Key Country Dynamics
    • 6.3.5.2. Target Disease Prevalence
    • 6.3.5.3. Competitive Scenario
    • 6.3.5.4. Regulatory Framework
    • 6.3.5.5. France Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.6. Italy
    • 6.3.6.1. Key Country Dynamics
    • 6.3.6.2. Target Disease Prevalence
    • 6.3.6.3. Competitive Scenario
    • 6.3.6.4. Regulatory Framework
    • 6.3.6.5. Italy Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.7. Spain
    • 6.3.7.1. Key Country Dynamics
    • 6.3.7.2. Target Disease Prevalence
    • 6.3.7.3. Competitive Scenario
    • 6.3.7.4. Regulatory Framework
    • 6.3.7.5. Spain Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.8. Denmark
    • 6.3.8.1. Key Country Dynamics
    • 6.3.8.2. Target Disease Prevalence
    • 6.3.8.3. Competitive Scenario
    • 6.3.8.4. Regulatory Framework
    • 6.3.8.5. Denmark Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.9. Sweden
    • 6.3.9.1. Key Country Dynamics
    • 6.3.9.2. Target Disease Prevalence
    • 6.3.9.3. Competitive Scenario
    • 6.3.9.4. Regulatory Framework
    • 6.3.9.5. Sweden Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.3.10. Norway
    • 6.3.10.1. Key Country Dynamics
    • 6.3.10.2. Target Disease Prevalence
    • 6.3.10.3. Competitive Scenario
    • 6.3.10.4. Regulatory Framework
    • 6.3.10.5. Norway Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
• 6.4. Asia Pacific
  • 6.4.1. SWOT Analysis
  • 6.4.2. Asia Pacific Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.3. Japan
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Target Disease Prevalence
    • 6.4.3.3. Competitive Scenario
    • 6.4.3.4. Regulatory Framework
    • 6.4.3.5. Japan Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.4. China
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Target Disease Prevalence
    • 6.4.4.3. Competitive Scenario
    • 6.4.4.4. Regulatory Framework
    • 6.4.4.5. China Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.5. India
    • 6.4.5.1. Key Country Dynamics
    • 6.4.5.2. Target Disease Prevalence
    • 6.4.5.3. Competitive Scenario
    • 6.4.5.4. Regulatory Framework
    • 6.4.5.5. India Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.6. Australia
    • 6.4.6.1. Key Country Dynamics
    • 6.4.6.2. Target Disease Prevalence
    • 6.4.6.3. Competitive Scenario
    • 6.4.6.4. Regulatory Framework
    • 6.4.6.5. Australia Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.7. Thailand
    • 6.4.7.1. Key Country Dynamics
    • 6.4.7.2. Target Disease Prevalence
    • 6.4.7.3. Competitive Scenario
    • 6.4.7.4. Regulatory Framework
    • 6.4.7.5. Thailand Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.4.8. South Korea
    • 6.4.8.1. Key Country Dynamics
    • 6.4.8.2. Target Disease Prevalence
    • 6.4.8.3. Competitive Scenario
    • 6.4.8.4. Regulatory Framework
    • 6.4.8.5. South Korea Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
• 6.5. Latin America
  • 6.5.1. SWOT Analysis
  • 6.5.2. Latin America Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.5.3. Brazil
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Target Disease Prevalence
    • 6.5.3.3. Competitive Scenario
    • 6.5.3.4. Regulatory Framework
    • 6.5.3.5. Brazil Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Target Disease Prevalence
    • 6.5.4.3. Competitive Scenario
    • 6.5.4.4. Regulatory Framework
    • 6.5.4.5. Mexico Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.5.5. Argentina
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Target Disease Prevalence
    • 6.5.5.3. Competitive Scenario
    • 6.5.5.4. Regulatory Framework
    • 6.5.5.5. Argentina Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
• 6.6. MEA
  • 6.6.1. SWOT Analysis
  • 6.6.2. MEA Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.6.3. South Africa
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Target Disease Prevalence
    • 6.6.3.3. Competitive Scenario
    • 6.6.3.4. Regulatory Framework
    • 6.6.3.5. South Africa Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.6.4. Saudi Arabia
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Target Disease Prevalence
    • 6.6.4.3. Competitive Scenario
    • 6.6.4.4. Regulatory Framework
    • 6.6.4.5. Saudi Arabia Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.6.5. UAE
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Target Disease Prevalence
    • 6.6.5.3. Competitive Scenario
    • 6.6.5.4. Regulatory Framework
    • 6.6.5.5. UAE Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)
  • 6.6.6. Kuwait
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Target Disease Prevalence
    • 6.6.6.3. Competitive Scenario
    • 6.6.6.4. Regulatory Framework
    • 6.6.6.5. Kuwait Clinical Workflow Solutions Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Share Analysis, 2022
• 7.4. Company Profiles/Listing
  • 7.4.1. Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.)
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Cerner Corporation (acquired by Oracle Corporation)
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. NXGN Management, LLC
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. McKesson Corporation
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Koninklijke Philips N.V.
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. Cisco Systems, Inc.
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Getinge AB.Cisco
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. Vocera Communications, Inc.
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Spok Inc.
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. AMETEK, Inc.
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives